Australian Nobel Laureate Barry Marshall — lauded for his discovery of the stomach-dwelling bacterium Helicobacter pylori's role in gastritis and peptic-ulcer disease — plans to put the bug that made him famous to use in science's battle against the flu, Bloomberg reports. By mid-2013, Marshall said he expects the biotech firm he founded, Ondek Ltd., to report results for a clinical trial of a drinkable flu vaccine.